From Our Partners
Monday, July 4, 2022
News on Pathogens and Preparedness
Global Biodefense
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe
No Result
View All Result
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe
No Result
View All Result
Global Biodefense
No Result
View All Result
Home CBRNE

What Will the CBRNE Defense Act of 2015 Cost?

by Global Biodefense Staff
December 1, 2015

The Congressional Budget Office today published a cost estimate for H.R. 3875, which would establish the Chemical, Biological, Radiological, Nuclear, and Explosives Office in the Department of Homeland Security (DHS), consisting of existing offices in DHS.

The legislation also would require the Government Accountability Office (GAO), within two years of the bill’s enactment, to prepare a report to the Congress on DHS research and development programs relating to explosives and chemical, biological, radiological, and nuclear threats.

H.R. 3875 was introduced on Nov. 2, 2015 by Rep. McCaul, Michael T. (R-TX). The mission of the CBRNE Office is to coordinate, strengthen, and provide chemical, biological, radiological, nuclear, and explosives (CBRNE) capabilities in support of homeland security.

The CBRNE Office will be headed by an Assistant Secretary for the Chemical, Biological, Radiological, Nuclear, and Explosives Office, who shall be appointed by the President and approved by the Senate.

Responsibilities of the Assistant Secretary shall include:

  • Develop, coordinate, and maintain overall CBRNE strategy and policy for DHS
  • Develop, coordinate, and maintain for the DHS periodic CBRNE risk assessments
  • Serve as the primary Department representative for coordinating CBRNE activities with other Federal departments and agencies
  • Provide oversight for DHS preparedness for CBRNE threats
  • Provide support for operations during CBRNE threats or incidents

The Director of the Chemical Division, the Director of the Biological Division, the Director of the Nuclear Division, and the Director of the Explosives Division shall report directly to the Assistant Secretary.

The functions, personnel, budget authority, and assets of the following offices would be transferred to the CBRNE Office:

  • The Office of Health Affairs, including the Chief Medical Officer and the National Biosurveillance Integration Center
  • The Domestic Nuclear Detection Office (and redesignated as the Nuclear Division)
  • CBRNE threat awareness and risk assessment activities of the Science and Technology Directorate.
  • The CBRNE functions of the Office of Policy and the Office of Operations Coordination.
  • The Office for Bombing Prevention of the National Protection and Programs Directorate

Based on information from the department on its current plans to consolidate the offices affected by the bill, CBO estimates that implementing H.R. 3875 would not significantly affect DHS spending. Based on the cost of similar reports, they estimate that it would cost GAO less than $1 million over the 2016-2017 period to prepare the report required by the bill.

CBO estimates that enacting H.R. 3875 would not increase net direct spending or on-budget deficits in any of the four consecutive 10-year periods beginning in 2026.

From Our Partners
Tags: Chemical Detection

Related Posts

BARDA and JPEO-CBRND Back Cepheid’s Multiplex Test for Influenza, SARS-CoV2 and RSV
Health Security

Resurgent COVID-19, Flu and Other Viruses are Pushing New Zealand’s Health System to the Limit

June 2, 2022
NIH to Further Invest in Point-of-Care Technologies Research Network
Biodetection

NIH to Further Invest in Point-of-Care Technologies Research Network

May 10, 2022
Supplemental Funding for Research at NIAID Regional Biocontainment Laboratories
Biosecurity

Supplemental Funding for Research at NIAID Regional Biocontainment Laboratories

May 5, 2022
Federal Select Agent Program Clarifies Requirements for Botulinum Neurotoxin Gene Constructs
Health Security

Federal Select Agent Program Clarifies Requirements for Botulinum Neurotoxin Gene Constructs

May 4, 2022
Load More

Latest News

Poliovirus Detected in London Sewage: Response Measures Emphasize Wastewater Surveillance and Vaccination Gaps

Poliovirus Detected in London Sewage: Response Measures Emphasize Wastewater Surveillance and Vaccination Gaps

June 22, 2022
Monkeypox Diagnostics: CDC Authorizes Five Commercial Lab Companies

Monkeypox Diagnostics: CDC Authorizes Five Commercial Lab Companies

June 22, 2022
UK Health Security Agency Widens Monkeypox Vaccine Umbrella for Outbreak Control

UK Health Security Agency Widens Monkeypox Vaccine Umbrella for Outbreak Control

June 21, 2022
Influenza Research

New Way to Identify Influenza A Virus Lights Up When Specific Virus Targets are Present

June 20, 2022

Subscribe

  • About
  • Contact
  • Privacy
  • Subscribe

© 2022 Stemar Media Group LLC

No Result
View All Result
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe

© 2022 Stemar Media Group LLC